Chlamydia pneumoniae is a widespread pathogen responsible for upper and lower respiratory tract infections, in addition to a wide range of human and animal diseases 9 . The range of hosts known to be infected by C. pneumoniae has expanded to several species of reptiles, such as puff adders (Bitis arietans), fl ap-necked chameleons (Chameleo dilepis), green turtles (Chelonia mydas), Nile crocodiles (Crocodylus niloticus), green iguanas (Iguana iguana) and Burmese pythons (Python molurus bivittatus) [1] [2] [3] 7, 9 . Lesions are varied and include histiocytic granulomas (puff adders), granulomatous infl ammation (fl ap necked chameleons), necrotizing enteritis (green iguanas), necrotizing myocarditis (green turtles), and proliferative pneumonia (Burmese pythons) 7 . However, in humans, C. pneumoniae infections range from asymptomatic to severe respiratory diseases, including pneumonia. Previous studies have reported seroprevalence values of 50% by the age of 20 years and 80% in the elderly 3 . Genome characterization of the C. pneumoniae sequence detected in Australian reptiles and amphibians showed 99% homology with the human sequence, revealing their potential role in the zoonotic transmission from reptiles to humans 11 . Recently, at a Recreation Center in Cordoba province, a specimen of reticulated python (Python reticulata) presented symptoms compatible with proliferative pneumonia, which led to the development of this investigation. The aim of this study was to describe the presence of C. pneumoniae in several species of reptiles in Córdoba and in their caregivers, and to evaluate the presence of specifi c antibodies against C. pneumoniae in the personnel.
We analyzed 27 cloacal swab samples from 19 reptiles at a recreational area using a specifi c nested-PCR for C. pneumoniae 8 . In May 2011, we obtained 1 cloacal swab from the reticulated python with symptoms compatible with proliferative pneumonia and 18 samples of reptiles living together. In December 2011, resampling of only 8 of these reptiles could be conducted.
The cotton swabs were placed in 1 ml sucrose-phosphateglutamate (SPG) and 200 µl was subjected to DNA extraction using the Accuprep Genomic DNA Extraction Kit (BIONEER, Alameda, CA, USA) according to the manufacturer's instructions. DNA AR39 C. pneumoniae (ATCC53592) was used as positive control. Negative controls (deionized H 2 O instead of template DNA) were included in all PCR reaction sets. First, 5 µl of DNA extract was used to amplify a fragment of RNA polymerase beta subunit gene (rpoB) using primers HL1 (GTT GTT CAT GAA GGC CTA CT)/ HR1 (TGC ATA ACC TAC GGT GTG TT) and N1 (AGT TGA GCA TAT TCG TGA GG)/ N2 (TTT ATT TCC GTG TCG TCC AG) as previously described by Mass et al. 8 . Positive samples were sequenced to corroborate the species. For sequence analysis, the nested polymerase chain reaction products were purifi ed with the QIAquick Gel Extraction Kit (Qiagen, Valencia, CA, USA) and subjected to direct nucleotide sequencing reaction in both directions using an ABI automatic sequencer (Applied Biosystems, Foster City, CA, USA). C. pneumoniae identifi cation was confi rmed by phylogenetic analysis.
Human pharyngeal swabs were also analyzed by a nested-PCR of C. pneumoniae 8 . Furthermore, sera from the 6 healthy caregivers were tested for C. pneumoniae antichlamydial immunoglobulin G (IgG) and IgM using the microimmunofl uorescence assay (MIF), according to the manufacturer's instructions (Bion Enterprises ® , France). In this test, C. pneumoniae elementary bodies were purifi ed by removal of genus-reactive LPS. Since this technique has very low cross-reactivity with other Chlamydophila species, it is recommended for the differential diagnosis of these agents in humans.
The rpoB sequences obtained were submitted to the GenBank (accession numbers are shown in Table 1 ) and alignment using the ClustalX program was performed (Conway Institute UCD Dublin, Dublin, Ireland) 12 . The maximum likelihood tree was constructed with the PhyML 3.0 software (Université de Montpellier, Montpellier, France) 5 . The model of nucleotide substitution for the data set analyzed was selected according to the Akaike Information Criterion implemented in the ModelTest 3.7 software (Universidad de Vigo, Galicia, Spain) 10 .
la circulación de este agente en el centro recreativo donde se realizó este estudio, lo que podría explicar la exacerbada respuesta inmunitaria en los cuidadores; este hallazgo sugiere la presencia de un potencial ciclo zoonótico. Se reporta aquí por primera vez la detección de C. pneumoniae en reptiles en Argentina. © 2013 Asociación Argentina de Microbiología. Publicado por Elsevier España, S.L. Todos los derechos reservados. . DNA of C. pneumoniae was not detected in samples from the symptomatic reticulated python, probably because at the time of collection, this reptile was isolated and had already received specifi c antibiotic treatment. PCR products suitable for sequencing were obtained from 6 reptiles. Sequence analysis confi rmed that the amplicons obtained belonged to C. pneumoniae (Fig. 1) . These fi ndings demonstrated that C. pneumoniae is capable of infecting several species of snakes and turtles, broadening the range of reptiles known to be infected by this primarily human pathogen. After confi rmation of infection, reptiles were subjected to specifi c antibiotic treatment. All the caregivers' pharyngeal swabs tested negative for C. pneumoniae, excluding active human infection.
In the second visit to the recreational centre in December, all cloacal and pharyngeal swabs analyzed were negative for C. pneumoniae.
In terms of immune response, IgM antibodies anti-C. pneumoniae were not detected in the caregivers' sera tested in May. One of the caregivers who maintained sporadic contact with the animals presented IgG titers of 1:512. Three caregivers with periodic contact showed IgG titers of 1:2048. One susceptible caregiver [IgG (-)] was the only worker who always used protection when handling the animals or cleaning their excreta. In December, the caregiver who used protective equipment remained susceptible while IgG levels remained elevated in the others (1:2048). The immune status of a new caregiver who had reported pneumonia in September showed high titers of IgG anti-C. pneumoniae (1:4096); however specifi c IgM was not detected.
The presence of C. pneumoniae strains in reptiles is important because this bacterium is a common cause of human pneumonia and bronchitis throughout the world; in addition, it has recently been associated with several chronic diseases, including coronary heart disease, Alzheimer's disease, and multiple sclerosis 3, 4, 13 . Although C. pneumoniae DNA or specifi c IgM was not detected in the caregivers, the detection of C. pneumoniae DNA in the animals demonstrated the circulation of this agent in the recreational park and supports the exacerbated immune response in people handling the reptiles, which suggests a potential zoonotic cycle. Respiratory diseases and excretion of this bacterium in the reptiles were attenuated by specifi c antibiotic treatment. The implementation of biosecurity measures is essential to prevent transmission, as demonstrated by our results.
In our study, as well as in other reports in a range of reptiles (snakes, iguanas, chameleons) and amphibians (frogs, turtles), the relationship of our sequences with other reference data sets of chlamydiae indicates that although our sequences belonged to the C. pneumoniae branch, they are quite distinct from the human TWAR strain (Fig. 1) 1,6,11 . Even though a limited amount of sequences were analyzed, we found that all C. pneumoniae sequences clustered among them and revealed segregation with sequences of human strains. Although transmission among humans is believed to occur from person to person through respiratory secretions 3, 13 , until more is known about the epidemiology, pathogenicity, and transmission of C. pneumoniae strains recovered from captive and wild populations of cold-blooded animals, their zoonotic potential must be considered. Moreover, because of the increasing ownership of reptiles as pets, caution must be exercised during direct handling of these animals.
Isolation and characterization of reptile C. pneumoniae strains are required to assess their clinical impact and possible zoonotic potential.
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